European Equity Partners
Lead investor in a small number of growth-stage life sciences companies, working closely with management
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Series A, Series B+, Growth
- Sector focus
- Biotech & Life Sciences, Hardware & Robotics
- Cheque size
- Above €3M
- Fund size
- Undisclosed
- Website
- eeplp.com
European Equity Partners (EEP) is a privately owned investment firm focused on life sciences, with more than 25 years of investment experience in the sector. It backs early-stage and growth companies aiming to build best-in-class technologies, and occasionally invests in special situations.
EEP deliberately holds few companies so that it can work closely with founders and management, typically as lead investor. Its best-known holding is CMC Biologics, now AGC Biologics, which grew into an international contract development and manufacturing organisation during EEP's ownership. The advisory arm is based in the City of London and is FCA-regulated, with the fund manager in Guernsey.
← All investors · Is this your organisation? Request an update
More investors in the directory
FirstPartyCapital
Specialist investor in AI, data and outcomes-based technology for the marketing and advertising sector
Elbow Beach
Early-stage investor in British clean technologies that cut emissions while improving customer economics
Selvedge Venture
Pre-seed to Series A investor in biotech and data-driven start-ups tackling age-related disease
SFV
Seed to Series B investor in urban, energy and industrial infrastructure technology
Zinal Growth
Growth investor partnering with founders building generational technology companies
Rockley Group
Invests in and advises technology businesses focused on sustainability, energy and resource efficiency
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.